Here we present an experimental approach based on recent advancements in epigenetic editing, namely CRISPRoff (9), to enable the study of the impact of different MGMT promoter region methylation patterns in isogenic glioma cell lines. This evidence concerns the gene MGMT and central nervous system cancer.